HealthEquity Capital Surpluse from 2010 to 2024

HQY Stock  USD 103.57  0.19  0.18%   
HealthEquity Capital Surpluse yearly trend continues to be fairly stable with very little volatility. Capital Surpluse is likely to outpace its year average in 2024. During the period from 2010 to 2024, HealthEquity Capital Surpluse regression line of annual values had r-squared of  0.81 and arithmetic mean of  601,531,066. View All Fundamentals
 
Capital Surpluse  
First Reported
2014-07-31
Previous Quarter
1.8 B
Current Value
1.8 B
Quarterly Volatility
626.6 M
 
Yuan Drop
 
Covid
Check HealthEquity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HealthEquity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 160.7 M, Interest Expense of 58.2 M or Selling General Administrative of 108.8 M, as well as many indicators such as Price To Sales Ratio of 6.57, Dividend Yield of 0.0735 or PTB Ratio of 5.64. HealthEquity financial statements analysis is a perfect complement when working with HealthEquity Valuation or Volatility modules.
  
Check out the analysis of HealthEquity Correlation against competitors.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.

Latest HealthEquity's Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of HealthEquity over the last few years. It is HealthEquity's Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in HealthEquity's overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

HealthEquity Capital Surpluse Regression Statistics

Arithmetic Mean601,531,066
Geometric Mean426,431,599
Coefficient Of Variation82.58
Mean Deviation455,408,746
Median261,237,000
Standard Deviation496,734,636
Sample Variance246745.3T
Range1.2B
R-Value0.90
Mean Square Error50392.7T
R-Squared0.81
Slope99,988,025
Total Sum of Squares3454434.2T

HealthEquity Capital Surpluse History

20241.4 B
20231.3 B
20201.2 B
2019818.8 M
2018305.2 M
2017261.2 M
2016232.1 M

About HealthEquity Financial Statements

HealthEquity investors use historical fundamental indicators, such as HealthEquity's Capital Surpluse, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in HealthEquity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Surpluse1.3 B1.4 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for HealthEquity Stock Analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.